Crossmark

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2020.07.003

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cortegiani, A.

Ippolito, M.

Greco, M.

Granone, V.

Protti, A.

Gregoretti, C.

Giarratano, A.

Einav, S.

Cecconi, M.
License Information

Text and Data Mining valid from 2021-01-01

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2020-07-15
More Information

This article is maintained by: Elsevier

Article Title: Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

Journal Title: Pulmonology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2020.07.003

Content Type: article

Copyright: © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.